Developer docs
API playgroundTry for free, no card

Search company profiles

CorTec

Full company profile

uuid0000iqq

Namestring
CorTec
Legal namestring
CorTec GmbH
Company typeenum
Private
Founded yearint
2014
Descriptiontext

CorTec GmbH is a Freiburg, Germany-based medical device company founded in 2014 (per company history; firmographic data indicates 2010) that operates two integrated business divisions: a CDMO/MedTech services arm providing design, development, and manufacturing of active implantable neurotechnology for third parties, and a clinical-stage Brain Interchange initiative developing the company's own fully implantable brain-computer interface platform. The company employs 51-100 people at its Freiburg cleanroom facility, with US clinical operations anchored at Harborview Medical Center in Seattle.

The technology stack centers on a proprietary 32-channel, fully implantable, bidirectional closed-loop BCI system (Brain Interchange System and Brain Interchange ONE) that combines wireless power and data transmission, real-time neural recording at 1 kHz with 16-bit resolution, sub-40ms closed-loop latency, and adaptive cortical stimulation. Supporting the platform is a vertically integrated product portfolio including °AirRay cuff, grid, paddle, and percutaneous electrodes, high-channel ceramic hermetic packaging, silicone overmolding, interconnection components, a custom ASIC micro-chip for neural signal processing, AES 128-encrypted RF-Link wireless technology, IEC 62304-compliant firmware/bootloader, and CorTec Cloud Services with C/C++, Python, and Matlab APIs.

CorTec monetizes through project-based CDMO contracts (tiered upfront payments from 100% for projects under €5,000 to 30% for projects over €25,000, with monthly invoicing for work-in-progress), sale of off-the-shelf electrode components and evaluation kits, and — at an investigational stage — the Brain Interchange platform sold to academic and clinical research users under an FDA masterfile. Customers include neurotech and MedTech companies (Tengable, Heraeus Medevio partner channel), leading academic medical centers (University of Washington, UCLA, University of Osaka, UMC Utrecht, UMC Tübingen, Harborview Medical Center), and the broader BCI research ecosystem (70+ institutes, 100+ publications). In April 2026 CorTec became the first European company and first BCI worldwide to hold both FDA Breakthrough Device Designation and FDA TAP Program acceptance for stroke motor rehabilitation, and is currently raising a $40-50 million round to fund pivotal trials and US commercialization.

Short descriptiontext

CorTec is a German medical device company that designs and manufactures active implantable neurotechnology systems and provides CDMO services for neuromodulation and brain-computer interface applications to neurotech companies and academic researchers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersFreiburg, Germany
HQ citystring
Freiburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
active implantable devices, brain-computer interfaces, neuromodulation systems, neural recording electrodes, implantable medical devices
Industry1 code
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Active Implantable Neurotechnology
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Custom Development & Manufacturing (CDMO)
TypeProfessional Services
Description

CorTec provides end-to-end design, development, and manufacturing services for active implantable medical devices. Services include consulting and feasibility studies, development and prototyping, validation and design transfer, technical documentation, and commercial manufacturing. Revenue is generated through project-based fees, with payment terms including upfront payments (100% for projects under €5,000, 30% for projects over €25,000, 50% for projects between €5,000-25,000) and monthly invoicing based on work progress.

cortec-neuro.com
2Off-the-Shelf Components and Products
TypeHardware Sales
Description

Sale of standardized implantable neurotechnology components including cuff electrodes, grid electrodes, paddle electrodes, percutaneous electrodes, high-channel packaging, and silicone overmolding. Products available for approved medical devices, clinical feasibility studies, and pre-clinical markets.

cortec-neuro.com
3Brain Interchange System
TypeHardware Sales
Description

Complete implantable BCI systems and evaluation kits sold to research institutions and clinical trial sites for investigational use. Platform is backed by FDA masterfile to reduce regulatory burden for partners.

cortec-neuro.com
4Strategic Partnership Services
TypeLicensing Royalties
Description

Partnership arrangements with companies like Heraeus Medevio for co-development and market access, combining CorTec's electrode and system expertise with partner distribution capabilities.

cortec-neuro.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details2 tiers
1Custom Design Projects - Tiered by Project Value
ModelOtherBilling cadenceMulti-year contract
Notes

Projects under €5,000: 100% upfront payment; Projects €5,000-25,000: 50% upfront payment; Projects over €25,000: 30% upfront payment. Balance invoiced monthly according to work progress.

cortec-neuro.com
2Standard Component Products
ModelOtherBilling cadencePay-as-you-go
Notes

Products include cuff electrodes, grid electrodes, paddle electrodes, percutaneous electrodes available off-the-shelf or as custom adaptations. Pricing not publicly disclosed - quote-based.

cortec-neuro.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Brain Interchange
Description

Closed-loop brain-computer interface platform for adaptive neurotherapy and stroke rehabilitation. The Brain Interchange System is an investigational device designed for therapeutic cortical stimulation to support motor recovery after chronic ischemic stroke.

brain-interchange.com
Core offering1 text field

CorTec develops and manufactures active implantable neurotechnology systems, including electrodes, hermetic packaging, electronics, and embedded software for neuromodulation and brain-computer interface applications. The company operates a CDMO business serving neurotech and MedTech customers with custom design, prototyping, validation, and commercial manufacturing, and also markets its own Brain Interchange 32-channel closed-loop BCI platform for therapeutic applications including stroke rehabilitation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • First patient demonstrated stronger motor recovery in 6 weeks than in the entire previous year using Brain Interchange BCI system
+4 more records
Product overview1 text field

CorTec operates two distinct business divisions: (1) CDMO/MedTech/Industry services providing custom development and manufacturing for active implantable devices, and (2) Brain Interchange BCI/Future Vision/Clinical Research focused on brain-computer interfaces. The product portfolio centers on the Brain Interchange System, a fully implantable 32-channel closed-loop BCI platform for stroke rehabilitation, epilepsy, and paralysis applications. Supporting the BCI system are °AirRay electrode product lines (Cuff, Grid, Paddle, and Percutaneous electrodes), High Channel Packaging for hermetic encapsulation, Silicone Overmolding, Cables and Connectors, and comprehensive Software and Electronics Development services. All products are developed and manufactured in Germany at CorTec's Freiburg facility.

Product and service11 records
1Brain Interchange System
CategoryBrain-Computer Interface Platform
Description

Fully implantable, bidirectional closed-loop brain-computer interface system with 32 channels for real-time neural recording and adaptive cortical electrical stimulation. Supports stroke rehabilitation, epilepsy management, and BCI applications for paralysis. Targeted at clinical research and investigational use.

2°AirRay Cuff Electrodes
CategoryNeural Interface Electrodes
Description

Cuff electrodes providing electrical interface to the peripheral nervous system for neural signal recording, electrical stimulation, and blocking of neural signal propagation. Available in Tunnel, Sling, Spiral, and Helix designs for various nerve diameters. For neurotech and MedTech developers.

3°AirRay Grid Electrodes
CategoryNeural Interface Electrodes
Description

Flat grid and strip electrodes designed for ECoG or intraoperative recordings of the central nervous system. All contacts can record and stimulate. Available in configurations from 4x4 to 8x8 contacts with customizable shapes. For neuroscience and clinical applications.

4°AirRay Paddle Electrodes
CategoryNeural Interface Electrodes
Description

Paddle electrodes designed for spinal cord stimulation and central nervous system applications. Provides electrical interface with oblong electrode arrangements and optional fixation straps. For spinal cord stimulation developers.

5°AirRay Percutaneous Electrodes
CategoryNeural Interface Electrodes
Description

Percutaneous electrodes providing electrical interface to subcutaneous, intraspinal, or deep brain locations. Features 360-degree electrode contacts on flexible or pushable tubes for recording and stimulation. For DBS and deep brain applications.

6High Channel Packaging
CategoryImplant Components and Packaging
Description

Ceramic implant housing with hermetic sealing and robust insulation for durable implantable electronics. Includes miniature designs for smaller, lighter, less invasive implants and high-channel encapsulation solutions for complex signal processing. For implantable device manufacturers.

7Silicone Overmolding
CategoryImplant Components and Packaging
Description

Customized silicone overmoldings to protect encapsulated electronics in active implant devices. Enables tailored designs with various shapes and form factors, combined with hermetic encapsulation for seamless functionality and patient safety. For active implant developers.

8Cables and Connectors
CategoryImplant Components and Packaging
Description

Interconnection solutions including CorTec Inline Connector for DBS leads, Straight Wire and Coiled Cables with silicone tubing, and Standard Connectors (IS-1, Omnetics). External Connection Cable System also available. For active implantable device manufacturers.

9Software Development Services
CategoryCDMO Engineering Services
Description

Software development services for implantable devices including embedded firmware, IEC 62304-compliant development, RF-Link Technology, Bootloader, Unit Test Framework, Wearable apps, API development in C/C++, Python, and Matlab, and CorTec Cloud services. For implantable device developers.

10Electronics Development Services
CategoryCDMO Engineering Services
Description

Electronics development services for active implantable devices including PCB design, wireless communication modules, inductive powering, recording modules, stimulation modules, closed-loop modules, wearable devices, and test bench development. For active implant developers.

11CDMO Services
CategoryContract Design and Manufacturing
Description

Comprehensive design, development, and manufacturing services for active implantable medical devices covering consulting and feasibility, development and prototyping, validation and design transfer, technical documentation, and commercial manufacturing. For neurotech and MedTech companies.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Harborview Medical Center (UW Medicine)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-23
Description

Clinical trial site for CorTec's Brain Interchange IDE study in stroke rehabilitation. Located in Seattle, Harborview Medical Center has conducted three successful human implants as of April 2026. The partnership enables CorTec to gather safety and efficacy data for FDA approval process.

globenewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIH-funded clinical trial led by Principal Investigator Jeffrey G. Ojemann, MD from UW School of Medicine. The collaboration evaluates whether direct cortical electrical stimulation can enhance upper-limb motor recovery in stroke patients using CorTec's fully implantable BCI platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-PI Professor Steven C. Cramer from UCLA participates in the NIH-funded clinical trial evaluating Brain Interchange BCI system for stroke rehabilitation. UCLA collaboration brings additional clinical research expertise to the study.

4University of Osaka Graduate School of Medicine
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with Takufumi Yanagisawa's group published findings in Nature Scientific Data demonstrating Brain Interchange ONE's long-term ECoG recording capabilities. Study showed stable signal quality over many months under realistic conditions.

cortec-neuro.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

INTENSE Project - first European study using Brain Interchange for BCI-based communication in everyday life. Participants with severe paralysis control digital devices using brain signals alone from home. Dr. Mariska van Steensel leads the research.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Strategic partnership addressing needs of the neuromodulation market. CorTec and Heraeus Medevio co-hosted on-demand webinar on 'Increasing Speed to Market for Neuromodulation Leads Through Early-Stage Device Design' featuring insights from both companies' experts.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Startup partner selecting CorTec as strategic partner for neurotechnology development. CEO Shai Feinsod stated CorTec exemplifies the trust and collaboration essential for startup success in neurotech.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative project exploring foundations for novel rehabilitation systems for paralyzed people using CorTec technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

High-profile implantable BCI developer with a high-channel, robotically implanted device and significantly larger capital base. Direct competitor targeting similar motor and communication indications.

TypeDirect peer
Description

Developer of a less-invasive, vascular (stentrode) BCI for paralysis patients. Competes with CorTec on BCI-based communication and motor restoration use cases via a different surgical approach.

TypeBroad incumbent
Description

Global leader in neuromodulation (DBS, spinal cord stimulation, peripheral nerve stimulation). Competes with CorTec's Brain Interchange at the therapy-application level, though with established legacy systems rather than closed-loop BCI.

TypeBroad incumbent
Description

Major neuromodulation incumbent with DBS, spinal cord stimulation, and emerging closed-loop systems. Competes with CorTec in implantable neurostimulation therapy markets.

TypeBroad incumbent
Description

Large medical device contract manufacturer with capabilities in active implantable and neuromodulation components. Overlaps with CorTec's CDMO business as a broader, more diversified incumbent.

TypeDirect peer
Description

Pioneer in implantable BCI systems using the Utah Array with decades of human implant experience and a similar electrode-and-electronics platform. Closest direct competitor to CorTec's Brain Interchange system in clinical-stage implantable BCI for motor and communication applications.

TypeDirect peer
Description

Austrian BCI hardware and software provider featuring in-house invasive (ECoG) and non-invasive BCI systems. Directly competes with CorTec in supplying BCI platforms to research and clinical customers.

TypeDirect peer
Description

Developer of a thin-film cortical BCI interface (Layer 7) targeting motor restoration. Directly comparable implantable BCI competitor focused on cortical signal acquisition.

TypeDirect peer
Description

High-data-rate implantable BCI developer targeting motor and speech restoration. Competes with CorTec in the high-channel-count, fully implantable BCI category.

TypeBroad incumbent
Description

Larger medical device CDMO and strategic partner of CorTec for neuromodulation components. Comparable in the active-implantable device CDMO space but at significantly greater scale and broader therapeutic scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CorTec

Active Implantable Neurotechnologycortec-neuro.com

CorTec is a German medical device company that designs and manufactures active implantable neurotechnology systems and provides CDMO services for neuromodulation and brain-computer interface applications to neurotech companies and academic researchers.

What CorTec does

CorTec GmbH is a Freiburg, Germany-based medical device company founded in 2014 (per company history; firmographic data indicates 2010) that operates two integrated business divisions: a CDMO/MedTech services arm providing design, development, and manufacturing of active implantable neurotechnology for third parties, and a clinical-stage Brain Interchange initiative developing the company's own fully implantable brain-computer interface platform. The company employs 51-100 people at its Freiburg cleanroom facility, with US clinical operations anchored at Harborview Medical Center in Seattle.

The technology stack centers on a proprietary 32-channel, fully implantable, bidirectional closed-loop BCI system (Brain Interchange System and Brain Interchange ONE) that combines wireless power and data transmission, real-time neural recording at 1 kHz with 16-bit resolution, sub-40ms closed-loop latency, and adaptive cortical stimulation. Supporting the platform is a vertically integrated product portfolio including °AirRay cuff, grid, paddle, and percutaneous electrodes, high-channel ceramic hermetic packaging, silicone overmolding, interconnection components, a custom ASIC micro-chip for neural signal processing, AES 128-encrypted RF-Link wireless technology, IEC 62304-compliant firmware/bootloader, and CorTec Cloud Services with C/C++, Python, and Matlab APIs.

CorTec monetizes through project-based CDMO contracts (tiered upfront payments from 100% for projects under €5,000 to 30% for projects over €25,000, with monthly invoicing for work-in-progress), sale of off-the-shelf electrode components and evaluation kits, and — at an investigational stage — the Brain Interchange platform sold to academic and clinical research users under an FDA masterfile. Customers include neurotech and MedTech companies (Tengable, Heraeus Medevio partner channel), leading academic medical centers (University of Washington, UCLA, University of Osaka, UMC Utrecht, UMC Tübingen, Harborview Medical Center), and the broader BCI research ecosystem (70+ institutes, 100+ publications). In April 2026 CorTec became the first European company and first BCI worldwide to hold both FDA Breakthrough Device Designation and FDA TAP Program acceptance for stroke motor rehabilitation, and is currently raising a $40-50 million round to fund pivotal trials and US commercialization.

CorTec firmographics

Firmographics
Name
CorTec
Legal name
CorTec GmbH
Website
https://cortec-neuro.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
CorTec is a German medical device company that designs and manufactures active implantable neurotechnology systems and provides CDMO services for neuromodulation and brain-computer interface applications to neurotech companies and academic researchers.
Ownership category
akta.pro rank

CorTec industry classification

Industry
Product category
Active Implantable Neurotechnology
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Active implantable devices
  • Brain-computer interfaces
  • Neuromodulation systems
  • Neural recording electrodes
  • Implantable medical devices

Where CorTec is headquartered

Location

Headquarters

HQ city
Freiburg
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

CorTec business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Custom Development & Manufacturing (CDMO): CorTec provides end-to-end design, development, and manufacturing services for active implantable medical devices. Services include consulting and feasibility studies, development and prototyping, validation and design transfer, technical documentation, and commercial manufacturing. Revenue is generated through project-based fees, with payment terms including upfront payments (100% for projects under €5,000, 30% for projects over €25,000, 50% for projects between €5,000-25,000) and monthly invoicing based on work progress.
  2. Off-the-Shelf Components and Products: Sale of standardized implantable neurotechnology components including cuff electrodes, grid electrodes, paddle electrodes, percutaneous electrodes, high-channel packaging, and silicone overmolding. Products available for approved medical devices, clinical feasibility studies, and pre-clinical markets.
  3. Brain Interchange System: Complete implantable BCI systems and evaluation kits sold to research institutions and clinical trial sites for investigational use. Platform is backed by FDA masterfile to reduce regulatory burden for partners.
  4. Strategic Partnership Services: Partnership arrangements with companies like Heraeus Medevio for co-development and market access, combining CorTec's electrode and system expertise with partner distribution capabilities.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom Design Projects - Tiered by Project Value
OtherPay-as-you-goStandard Component Products

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

CorTec product offering

Product offering

Core offering

CorTec develops and manufactures active implantable neurotechnology systems, including electrodes, hermetic packaging, electronics, and embedded software for neuromodulation and brain-computer interface applications. The company operates a CDMO business serving neurotech and MedTech customers with custom design, prototyping, validation, and commercial manufacturing, and also markets its own Brain Interchange 32-channel closed-loop BCI platform for therapeutic applications including stroke rehabilitation.

Product overview

CorTec operates two distinct business divisions: (1) CDMO/MedTech/Industry services providing custom development and manufacturing for active implantable devices, and (2) Brain Interchange BCI/Future Vision/Clinical Research focused on brain-computer interfaces. The product portfolio centers on the Brain Interchange System, a fully implantable 32-channel closed-loop BCI platform for stroke rehabilitation, epilepsy, and paralysis applications. Supporting the BCI system are °AirRay electrode product lines (Cuff, Grid, Paddle, and Percutaneous electrodes), High Channel Packaging for hermetic encapsulation, Silicone Overmolding, Cables and Connectors, and comprehensive Software and Electronics Development services. All products are developed and manufactured in Germany at CorTec's Freiburg facility.

Differentiator

Problem solved

Functional benefit

Brands

  • Brain Interchange: Closed-loop brain-computer interface platform for adaptive neurotherapy and stroke rehabilitation. The Brain Interchange System is an investigational device designed for therapeutic cortical stimulation to support motor recovery after chronic ischemic stroke.

Products and services

  • Brain Interchange System Fully implantable, bidirectional closed-loop brain-computer interface system with 32 channels for real-time neural recording and adaptive cortical electrical stimulation. Supports stroke rehabilitation, epilepsy management, and BCI applications for paralysis. Targeted at clinical research and investigational use.
  • °AirRay Cuff Electrodes Cuff electrodes providing electrical interface to the peripheral nervous system for neural signal recording, electrical stimulation, and blocking of neural signal propagation. Available in Tunnel, Sling, Spiral, and Helix designs for various nerve diameters. For neurotech and MedTech developers.
  • °AirRay Grid Electrodes Flat grid and strip electrodes designed for ECoG or intraoperative recordings of the central nervous system. All contacts can record and stimulate. Available in configurations from 4x4 to 8x8 contacts with customizable shapes. For neuroscience and clinical applications.
  • °AirRay Paddle Electrodes Paddle electrodes designed for spinal cord stimulation and central nervous system applications. Provides electrical interface with oblong electrode arrangements and optional fixation straps. For spinal cord stimulation developers.
  • °AirRay Percutaneous Electrodes Percutaneous electrodes providing electrical interface to subcutaneous, intraspinal, or deep brain locations. Features 360-degree electrode contacts on flexible or pushable tubes for recording and stimulation. For DBS and deep brain applications.
  • High Channel Packaging Ceramic implant housing with hermetic sealing and robust insulation for durable implantable electronics. Includes miniature designs for smaller, lighter, less invasive implants and high-channel encapsulation solutions for complex signal processing. For implantable device manufacturers.
  • Silicone Overmolding Customized silicone overmoldings to protect encapsulated electronics in active implant devices. Enables tailored designs with various shapes and form factors, combined with hermetic encapsulation for seamless functionality and patient safety. For active implant developers.
  • Cables and Connectors Interconnection solutions including CorTec Inline Connector for DBS leads, Straight Wire and Coiled Cables with silicone tubing, and Standard Connectors (IS-1, Omnetics). External Connection Cable System also available. For active implantable device manufacturers.
  • Software Development Services Software development services for implantable devices including embedded firmware, IEC 62304-compliant development, RF-Link Technology, Bootloader, Unit Test Framework, Wearable apps, API development in C/C++, Python, and Matlab, and CorTec Cloud services. For implantable device developers.
  • Electronics Development Services Electronics development services for active implantable devices including PCB design, wireless communication modules, inductive powering, recording modules, stimulation modules, closed-loop modules, wearable devices, and test bench development. For active implant developers.
  • CDMO Services Comprehensive design, development, and manufacturing services for active implantable medical devices covering consulting and feasibility, development and prototyping, validation and design transfer, technical documentation, and commercial manufacturing. For neurotech and MedTech companies.

Quantifiable outcome

  • First patient demonstrated stronger motor recovery in 6 weeks than in the entire previous year using Brain Interchange BCI system
  • +4 more outcomes

Companies that use CorTec

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

CorTec technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

CorTec partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

  • Harborview Medical Center (UW Medicine)coreStrategic or Co-development Partner · 23 April 2026Clinical trial site for CorTec's Brain Interchange IDE study in stroke rehabilitation. Located in Seattle, Harborview Medical Center has conducted three successful human implants as of April 2026. The partnership enables CorTec to gather safety and efficacy data for FDA approval process.
  • University of WashingtoncoreStrategic or Co-development PartnerNIH-funded clinical trial led by Principal Investigator Jeffrey G. Ojemann, MD from UW School of Medicine. The collaboration evaluates whether direct cortical electrical stimulation can enhance upper-limb motor recovery in stroke patients using CorTec's fully implantable BCI platform.
  • UCLAcoreStrategic or Co-development PartnerCo-PI Professor Steven C. Cramer from UCLA participates in the NIH-funded clinical trial evaluating Brain Interchange BCI system for stroke rehabilitation. UCLA collaboration brings additional clinical research expertise to the study.
  • University of Osaka Graduate School of MedicinecoreStrategic or Co-development PartnerResearch collaboration with Takufumi Yanagisawa's group published findings in Nature Scientific Data demonstrating Brain Interchange ONE's long-term ECoG recording capabilities. Study showed stable signal quality over many months under realistic conditions.
  • University Medical Center UtrechtcoreStrategic or Co-development PartnerINTENSE Project - first European study using Brain Interchange for BCI-based communication in everyday life. Participants with severe paralysis control digital devices using brain signals alone from home. Dr. Mariska van Steensel leads the research.
  • Heraeus MedevioflagshipStrategic or Co-development PartnerStrategic partnership addressing needs of the neuromodulation market. CorTec and Heraeus Medevio co-hosted on-demand webinar on 'Increasing Speed to Market for Neuromodulation Leads Through Early-Stage Device Design' featuring insights from both companies' experts.
  • TengableminorStrategic or Co-development PartnerStartup partner selecting CorTec as strategic partner for neurotechnology development. CEO Shai Feinsod stated CorTec exemplifies the trust and collaboration essential for startup success in neurotech.
  • University Medical Center TübingenminorStrategic or Co-development PartnerCollaborative project exploring foundations for novel rehabilitation systems for paralyzed people using CorTec technology.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

CorTec competitors and assessment

Company assessment

Direct peers

  • Neuralink: High-profile implantable BCI developer with a high-channel, robotically implanted device and significantly larger capital base. Direct competitor targeting similar motor and communication indications.
  • Synchron: Developer of a less-invasive, vascular (stentrode) BCI for paralysis patients. Competes with CorTec on BCI-based communication and motor restoration use cases via a different surgical approach.
  • Blackrock Neurotech: Pioneer in implantable BCI systems using the Utah Array with decades of human implant experience and a similar electrode-and-electronics platform. Closest direct competitor to CorTec's Brain Interchange system in clinical-stage implantable BCI for motor and communication applications.
  • g.tec medical engineering: Austrian BCI hardware and software provider featuring in-house invasive (ECoG) and non-invasive BCI systems. Directly competes with CorTec in supplying BCI platforms to research and clinical customers.
  • Precision Neuroscience: Developer of a thin-film cortical BCI interface (Layer 7) targeting motor restoration. Directly comparable implantable BCI competitor focused on cortical signal acquisition.
  • Paradromics: High-data-rate implantable BCI developer targeting motor and speech restoration. Competes with CorTec in the high-channel-count, fully implantable BCI category.

Broad incumbents

  • Medtronic: Global leader in neuromodulation (DBS, spinal cord stimulation, peripheral nerve stimulation). Competes with CorTec's Brain Interchange at the therapy-application level, though with established legacy systems rather than closed-loop BCI.
  • Boston Scientific: Major neuromodulation incumbent with DBS, spinal cord stimulation, and emerging closed-loop systems. Competes with CorTec in implantable neurostimulation therapy markets.
  • Integer Holdings: Large medical device contract manufacturer with capabilities in active implantable and neuromodulation components. Overlaps with CorTec's CDMO business as a broader, more diversified incumbent.
  • Heraeus Medevio: Larger medical device CDMO and strategic partner of CorTec for neuromodulation components. Comparable in the active-implantable device CDMO space but at significantly greater scale and broader therapeutic scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

CorTec social profiles

Digital presence

CorTec compliance and trust

Trust signal

Compliance4 records

CorTec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CorTec leadership team

Management profile

Number of profiles

Profiles4 records

CorTec funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CorTec M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CorTec

What does CorTec do?

CorTec develops and manufactures active implantable neurotechnology systems, including electrodes, hermetic packaging, electronics, and embedded software for neuromodulation and brain-computer interface applications. The company operates a CDMO business serving neurotech and MedTech customers with custom design, prototyping, validation, and commercial manufacturing, and also markets its own Brain Interchange 32-channel closed-loop BCI platform for therapeutic applications including stroke rehabilitation.

Is CorTec a public or private company?

CorTec is a private company. It is classified as venture growth investor backed and is currently operating.

When was CorTec founded?

CorTec was founded in 2014. It employs 51 to 100 people.

Where is CorTec based?

CorTec is headquartered in Freiburg, Germany, in the Europe region.

How does CorTec make money?

Four revenue lines are on record. Custom Development & Manufacturing (CDMO) is the primary driver. The others are off-the-Shelf Components and Products, brain Interchange System and strategic Partnership Services.

Who are CorTec's main competitors?

Direct peers on record are Neuralink, Synchron, Blackrock Neurotech, g.tec medical engineering, Precision Neuroscience and Paradromics. Broad incumbents are Medtronic, Boston Scientific, Integer Holdings and Heraeus Medevio.

Does CorTec have an API?

Yes. CorTec offers API development for controlling the Brain Interchange system in C/C++, Python, and Matlab. The API enables developers to build custom applications that interface with the Brain Interchange BCI platform for neural recording and stimulation control. Developer documentation is at cortec-neuro.com/products-components/software-development.

What industry is CorTec in?

CorTec's product category is Active Implantable Neurotechnology. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO. Its NAICS code is 33451 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialCortec Brain Interface Electrodes Record Stable Signals For More Than Four YearsCorTec GmbH announced peer-reviewed data showing its cortical surface electrodes recorded stable neural signals for over four years in two non-human primates. In the animal still under study, 63 of 64 electrode contacts remained functional, with recordings showing consistent brain signatures. The results support the long-term stability needed for clinical brain-computer interfaces.FinanzNachrichten.deEQS-News: CorTec GmbH: CorTec-Hirnelektroden liefern seit mehr als vier Jahren stabile SignaleCorTec GmbH presented preclinical data showing its cortical surface electrodes recorded stable neural signals for over four years in two non-human primates, with 63 of 64 contacts remaining functional. The results were presented at the Graz BCI Conference and support the long-term stability of its Brain Interchange system, which is currently in clinical trials at the University of Washington.TradingViewCorTec Brain Interface Electrodes Record Stable Signals for More Than Four YearsCorTec GmbH announced peer-reviewed data showing its cortical surface electrodes recorded stable neural signals for over four years in two non-human primates. Of 64 contacts, 63 remained functional in the animal still under study, with recordings up to day 1,361. The results support the durability of its Brain Interchange system, which is in clinical evaluation.TradingViewCorTec GmbH Reports 4+ Years of Stable µECoG SignalsCorTec reported peer-reviewed preclinical data showing its cortical surface electrodes recorded stable signals for over four years in non-human primates, with 63 of 64 contacts still functional in one animal. The company is in U.S. clinical evaluation with three patients implanted in Seattle, and the same materials are used in Brain Interchange.In VivoCorTec’s BCI Shows Early Promise In Stroke Rehab With 8 to 12 Point FMA-UE GainsGerman BCI maker CorTec GmbH has reported early results from its ongoing safety trial showing that all three stroke patients implanted with its Brain Interchange system achieved Fugl-Meyer Upper Extremity (FMA-UE) gains of 8 to 12 points, meeting or approaching clinically meaningful thresholds for upper limb recovery. The company plans to resubmit to the FDA this week to advance into phase two of the study and enroll a fourth patient, pending regulatory approval. While the trial remains early-stage with a small cohort, the functional gains demonstrated suggest potential for CorTec's closed-loop BCI approach in stroke rehabilitation.NeuroNewsCorTec’s Brain Interchange BCI system enables stroke patient to control computer with thought aloneCorTec announced that the first participant in a University of Washington NIH-funded clinical trial successfully controlled a computer through thought alone using the Brain Interchange brain-computer interface system, including a demonstration playing Pong video game. The fully implanted, wireless BCI system demonstrated both therapeutic brain stimulation for stroke rehabilitation and real-time neural decoding for thought-based computer control using identical hardware and surgical placement. This marks the first reported instance worldwide of a single implanted wireless BCI achieving both capabilities in the same stroke patient.The Manila TimesCorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his MindCorTec GmbH announced that the first participant in the University of Washington's NIH-funded clinical trial of the Brain Interchange™ BCI system successfully controlled a computer through thought alone, including playing the Pong video game, using the same fully implanted wireless device previously placed for motor recovery after stroke. This marks the first reported instance worldwide in which a single fully implanted, wireless BCI system demonstrated both therapeutic brain stimulation for stroke rehabilitation and thought-based computer control in the same patient using identical hardware, achieved within approximately two hours of the participant being introduced to the concept with no system modification required.MassDeviceCorTec BCI allows patient to control computer with thought aloneCorTec announced a major milestone for its Brain Interchange brain-computer interface (BCI), with the first participant in a clinical trial at the University of Washington successfully controlling a computer using thought alone. This instance marks the first reported case of a fully implanted wireless BCI demonstrating both brain stimulation for stroke rehabilitation and thought-based computer control using the same hardware. Recent advances for the system include FDA breakthrough device designation and entry into the FDA’s TAP advisory program.GlobeNewswireCorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his MindCorTec GmbH announced that the first participant in a University of Washington NIH-funded clinical trial successfully controlled a computer through thought alone, including playing Pong, using their fully implanted, wireless Brain Interchange™ BCI system nine months post-device implantation. This marks the first reported instance worldwide where a single implanted BCI system demonstrated both therapeutic brain stimulation for stroke rehabilitation and thought-based computer control using identical hardware in the same patient. The Brain Interchange™ platform is also being developed for epilepsy management, BCI for paralysis, and treatment-resistant depression.GlobeNewswireCorTec’s Brain Interchange™ Accepted into FDA Total ProductCorTec GmbH announced that its Brain Interchange™ brain-computer interface system has been accepted into the FDA's Total Product Life Cycle Advisory Program (TAP), following a recent FDA Breakthrough Device Designation, placing the German company among a limited number of neurotech firms to achieve both recognitions. A third patient has been successfully implanted at Harborview Medical Center in Seattle as part of an ongoing NIH-funded clinical trial conducted by researchers from the University of Washington and UCLA, with the first patient demonstrating nine months of stable, fully implanted neural sensing and stimulation. The dual regulatory milestones and growing clinical evidence position CorTec as the first and only European company to reach this advanced stage of FDA-authorized BCI evaluation for therapeutic motor rehabilitation after stroke.